BR1100383A - Composto, e, composição farmacêutica - Google Patents

Composto, e, composição farmacêutica

Info

Publication number
BR1100383A
BR1100383A BR1100383-9A BR1100383A BR1100383A BR 1100383 A BR1100383 A BR 1100383A BR 1100383 A BR1100383 A BR 1100383A BR 1100383 A BR1100383 A BR 1100383A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR1100383-9A
Other languages
English (en)
Inventor
Michel L Belley
Serge Leger
Patrick Roy
Marc Labelle
Yi Bin Xiang
Daniel Guay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR1100383A publication Critical patent/BR1100383A/pt

Links

BR1100383-9A 1990-10-12 1997-04-30 Composto, e, composição farmacêutica BR1100383A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59688790A 1990-10-12 1990-10-12

Publications (1)

Publication Number Publication Date
BR1100383A true BR1100383A (pt) 2000-07-25

Family

ID=24389138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100383-9A BR1100383A (pt) 1990-10-12 1997-04-30 Composto, e, composição farmacêutica

Country Status (2)

Country Link
BR (1) BR1100383A (pt)
ZA (1) ZA918119B (pt)

Also Published As

Publication number Publication date
ZA918119B (en) 1992-08-26

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A (fi) Farmaceutiska kompositioner.
DE69101931T2 (de) Pharmazeutische Zusammensetzung.
FI944832A (fi) Farmaseuttinen koostumus
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
FI910310A0 (fi) Acesulfam-k-innehaollande komposition.
BR9200058A (pt) Composto e composicao farmaceutica
IT8920486A0 (it) Composizioni farmaceutiche.
FI893643A (fi) Farmaceutiska kompositioner.
MX9200622A (es) Composicion farmaceutica
DE69007908T2 (de) Shampoo-Zusammensetzung.
ITMI932540A0 (it) Composizione farmaceutica
UA26064A1 (uk) Фармацевтичhа композиція
BR9104279A (pt) Composicao e composto
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
BR1100383A (pt) Composto, e, composição farmacêutica
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
BR1100960A (pt) Composto, e, composição farmacêutica
BR1100691A (pt) Composto, e, composição farmacêutica
BR1101082A (pt) Composto, e, composição farmacêutica
FI916035A0 (fi) Ny farmaceutisk komposition.
MX9206975A (es) Composicion farmaceutica.

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
B23O Processing applications according to articles 230 and 231 of law 9.279/96: expedition cancelled
CAF Processing applications according to articles 230 and 231 of law 9.279/96: notification for applicant submission of comments
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
PC Transfer

Free format text: MERCK FROSST CANADA & CO./MERCK FROSST CANADA & CIE. (CA)

NB Patent issued - articles 230 and 231 of law 9279/96
NB Patent issued - articles 230 and 231 of law 9279/96
TKX1 Grant procedure suspended (cancelled) - according to articles 230 and 231 of law 9279/96
HKAN Grant procedure suspended (correction) - according to articles 230 and 231 of law 9279/96
HKAN Grant procedure suspended (correction) - according to articles 230 and 231 of law 9279/96
B23L Processing applications according to articles 230 and 231 of law 9.279/96: rectification

Free format text: REFERENTE AS RPI?S 1542 DE 25/07/00 E 1715 DE 18/11/03, QUANTO AO PRAZO DE VALIDADE E POR TER SIDOEXCLUIDO O APOSTILAMENTO. APOSTILA: CONCEDIDA A PATENTE COM EXCLUSAO DAS REIVINDICACOES 12, 13, 14, 15, 16, 21, 22, E 23.

B25A Requested transfer of rights approved

Owner name: MERCK FROSST CANADA LTD. (CA)

Free format text: TRANSFERIDO DE: MERCK FROSST CANADA AND CO. E MERCK FROSST CANADA AND CIE.